- Home
- ARES vs RGC Comparison
ARES vs RGC Comparison
Compare ARES & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARES
- RGC
- Stock Information
- Founded
- ARES 1997
- RGC 2014
- Country
- ARES United States
- RGC Hong Kong
- Employees
- ARES N/A
- RGC N/A
- Industry
- ARES Investment Managers
- RGC Medicinal Chemicals and Botanical Products
- Sector
- ARES Finance
- RGC Health Care
- Exchange
- ARES Nasdaq
- RGC Nasdaq
- Market Cap
- ARES 37.1B
- RGC 38.6B
- IPO Year
- ARES 2014
- RGC 2021
- Fundamental
- Price
- ARES $177.72
- RGC $14.66
- Analyst Decision
- ARES Buy
- RGC
- Analyst Count
- ARES 12
- RGC 0
- Target Price
- ARES $178.00
- RGC N/A
- AVG Volume (30 Days)
- ARES 1.4M
- RGC 2.8M
- Earning Date
- ARES 08-01-2025
- RGC 06-30-2025
- Dividend Yield
- ARES 2.53%
- RGC N/A
- EPS Growth
- ARES N/A
- RGC N/A
- EPS
- ARES 1.76
- RGC N/A
- Revenue
- ARES $4,266,223,000.00
- RGC N/A
- Revenue This Year
- ARES $16.09
- RGC N/A
- Revenue Next Year
- ARES $23.61
- RGC N/A
- P/E Ratio
- ARES $100.90
- RGC N/A
- Revenue Growth
- ARES 21.00
- RGC N/A
- 52 Week Low
- ARES $110.63
- RGC $0.08
- 52 Week High
- ARES $200.49
- RGC $83.60
- Technical
- Relative Strength Index (RSI)
- ARES 61.61
- RGC 45.32
- Support Level
- ARES $172.62
- RGC $9.39
- Resistance Level
- ARES $180.20
- RGC $30.00
- Average True Range (ATR)
- ARES 3.74
- RGC 6.44
- MACD
- ARES 0.42
- RGC -1.70
- Stochastic Oscillator
- ARES 87.38
- RGC 20.68
About ARES Ares Management Corporation
Ares Management Corp is an asset management company. It offers investors investment-related advice and strategies for capital growth. The company's operating segments include Credit Group, Private Equity Group, Real Assets, Secondaries Group, and Others. Its Credit Group generates maximum revenue and manages credit strategies across the liquid and illiquid spectrum. Private Equity Group manages investment strategies categorized as corporate private equity, infrastructure and power, and special opportunities, Real Estate Group manages comprehensive equity and debt strategies across real estate & infrastructure investments. The Secondaries Group invests in secondary markets across a range of alternative asset class strategies, including private equity, real estate, infrastructure, & credit.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.